Kelly Goode examines 2026–27 vaccine guidance for pharmacists, detailing updated flu, COVID-19, and RSV recommendations and coadministration.
Kelly Goode, PharmD, BCPS, FAPhA, FCCP
Advertisement
Articles by Kelly Goode, PharmD, BCPS, FAPhA, FCCP
Kelly Goode, PharmD, BCPS, FAPhA, FCCP, professor in the department of pharmacotherapy and outcomes science at Virginia Commonwealth University, discusses the current landscape of immunization recommendations.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
ACIP's Vacancy Leaves Pharmacists Navigating COVID-19 Confusion
2
COVID-19 in 2026: Why the Virus Still Threatens Vulnerable Patients
3
Tirzepatide Receives Expanded Approval for MACE in Patients With T2D
4
The Drug Price Paradox: PBMs, Pharmacies, and the Path to Affordability
5